Featured Research

from universities, journals, and other organizations

EBCT Scans Trump Angiography At Detecting Killer Heart Defect

Date:
October 11, 2005
Source:
Saint Louis University
Summary:
New Saint Louis University research shows electron-beam CT is more accurate than conventional catheter angiography.

EsatMemisoglu, M.D., assistant professor of radiology at Saint LouisUniversity School of Medicine, and his team – which included anotherradiologist and several cardiologists – studied 28 adults at a hearthospital and imaging center in Istanbul, Turkey, who had undergoneconventional X-ray angiography for chest pain or shortness of breathand then later underwent an EBCT.

In half of the patients,angiography showed a congenital abnormality – for example, a leftcoronary artery originating from the right side of the aorta, or viceversa. EBCT also detected the abnormalities, but in more than a thirdof the cases, it was able to provide information the angiography couldnot. Specifically, it could confidently determine whether the arterytraveled perilously between the aorta and pulmonary artery, puttingthat patient at risk for a heart attack or sudden death, Memisoglu says.

“Themost crucial clinical question is whether the artery is coursingbetween the aorta and pulmonary artery. Angiography did not always giveus the correct answer, but it was very easy to tell using EBCT,”Memisoglu says.

Traditional catheter angiography, an invasivetwo-dimensional projectional X-ray technique that involves passing acatheter through a patient’s groin artery to the heart vessels, iscommonly used when physical examinations and other non-invasive testsare found to be negative in younger patients who experience chest painor fainting during strenuous physical activity. However, catheterangiography “can lead to ambiguities because of its in defining complexvascular anatomy,” Dr. Memisoglu says.

In contrast, EBCT, whichuses a specialized stationary X-ray tube and a high-resolution detectorsystem, enables doctors to capture “practically blur-free”cross-sectional images of the beating heart, says Memisoglu.

Becauseof its speed in capturing images – the study is completed in fewer than30 seconds – patients don’t need medication to slow their heart rate.

EBCT,along with multi-slice computed tomography (MSCT) – which features amoving X-ray tube but is comparable to EBCT in diagnosis – producesstunning three-dimensional images of the heart that help radiologistsdetect congenital defects that otherwise might not have been picked up.EBCT and MSCT can also rule out the presence of significant coronaryartery blockages with a high degree of accuracy.

“Up to 40percent of all patients in the U.S. who go through invasive catheterangiography do not end up needing revascularization treatment, such asstenting or bypass surgery. That means a major role for MSCT and EBCTwould be gatekeeping – telling us which patients would benefit mostfrom an invasive procedure,” Memisoglu says.

Memisoglu also sees an economic advantage to using EBCT or MSCT scans in place of catheter angiography.

“Liberaluse of coronary catheterizations are costing taxpayers millions ofdollars, driving the cost of medical insurance and creating a burden onthe economy,” he says.

He predicts non-invasive scans – such asEBCT, MSCT and magnetic resonance imaging (MRI) – will one day replacecatheter angiography entirely to detect heart vessel blockages andcongenital abnormalities; conventional catheter angiography will thenbe used for treatment only, he suspects.

“We don’t want to blockaccess to catheter angiography for patients who really need it,”Memisoglu says. “But EBCT and MSCT can help avert the unnecessaryphysical and psychological consequences of an invasive procedure.”

Establishedin 1836, Saint Louis University School of Medicine has the distinctionof awarding the first M.D. degree west of the Mississippi River. SaintLouis University School of Medicine is a pioneer in geriatric medicine,organ transplantation, chronic disease prevention, cardiovasculardisease, neurosciences and vaccine research, among others. The Schoolof Medicine trains physicians and biomedical scientists, conductsmedical research, and provides health services on a local, national andinternational level.


Story Source:

The above story is based on materials provided by Saint Louis University. Note: Materials may be edited for content and length.


Cite This Page:

Saint Louis University. "EBCT Scans Trump Angiography At Detecting Killer Heart Defect." ScienceDaily. ScienceDaily, 11 October 2005. <www.sciencedaily.com/releases/2005/10/051011064123.htm>.
Saint Louis University. (2005, October 11). EBCT Scans Trump Angiography At Detecting Killer Heart Defect. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2005/10/051011064123.htm
Saint Louis University. "EBCT Scans Trump Angiography At Detecting Killer Heart Defect." ScienceDaily. www.sciencedaily.com/releases/2005/10/051011064123.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins